Polyelectrolyte Complex Drug Delivery System for Targeted Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing drug delivery systems face challenges in achieving targeted and controlled release of medicinal substances, particularly in terms of accuracy and speed of release at desired biomedically relevant sites.
Innovation Solution
A method involving the production of polyelectrolyte complexes by mixing polyanions and polycations in a non-stoichiometric ratio, with drugs added before, during, or after mixing, and applying the resulting complex to a medical device or surface for localized and controlled drug release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If classic systems of surfactant or (co)polymer liposomes are used, then drug delivery can be achieved, but targeting accuracy and controlled release speed at desired sites are insufficient
Solution Approach 1:
The patent changes the fundamental parameters of the drug delivery system by using polyelectrolyte complexes instead of traditional liposomes. The complexation ratio, molecular weight, and charge characteristics of the polyelectrolytes are optimized to achieve both accurate targeting and controlled release kinetics, resolving the contradiction between targeting precision and release speed.
Solution Approach 2:
The patent employs composite polyelectrolyte complex structures combining cationic and anionic polyelectrolytes in specific ratios. This composite approach creates nanoparticles with tailored surface properties for enhanced targeting and controlled drug release, simultaneously improving both targeting accuracy and release control.
2Reliability
If polyelectrolyte complexes are used for drug delivery, then controlled release can be achieved, but the complexity of the production process increases
Solution Approach 1:
The patent performs preliminary complexation of polyelectrolytes before drug incorporation, creating pre-formed nanoparticles with controlled structure and charge distribution. This preliminary action simplifies subsequent drug loading and ensures consistent release characteristics, reducing overall process complexity while maintaining controlled release reliability.
Solution Approach 2:
By optimizing the complexation ratio and selecting appropriate molecular weights for the polyelectrolytes, the patent achieves controlled release with simplified processing. The parameter optimization allows for straightforward production protocols while maintaining reliable controlled release performance.
3Productivity
If drugs are added before or during polyelectrolyte mixing, then drug incorporation efficiency increases, but control over release kinetics is reduced
Solution Approach 1:
The patent incorporates drugs during the complexation process itself, which is a preliminary action that ensures uniform distribution and controlled incorporation. This timing allows the drug to be integrated into the forming nanoparticle structure, maintaining control over release kinetics while achieving high incorporation efficiency.
Solution Approach 2:
The polyelectrolyte complex acts as an intermediary structure that controls drug release. By forming the complex during the mixing process, the patent uses the polyelectrolyte structure as a mediator that both incorporates the drug efficiently and maintains controlled release kinetics through its regulated degradation and drug diffusion characteristics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables a locally targeted and controllable release of drugs, with adjustable release kinetics through the use of polyelectrolyte complexes forming nanoscale particles with a hydrophobic core and hydrophilic shell, providing a stable and irreversible surface-bound layer for delayed and controlled drug delivery.
Implementation Method 1
These are produced by complexing oppositely charged polyelectrolytes (PEL). Upon this complexation, the PECs can be formed in the form of dispersed spheroidal-like PEC nanoparticles.
Implementation Method 2
PEK nanoparticles consist of a rather hydrophobic charge-compensated core and a hydrophilic shell formed by the respective excess PEL (polycation or polyanion).
Implementation Method 3
The osmotic pressure difference between the particle interior and the environment was named as an important driving force behind the release.
Implementation Method 4
The polyelectrolyte complex is applied to the surface or surface area of a medicinal device or to the surface or surface area directly positioned at the site where the drug is to be released.
Data Source
AI summary
The invention relates to the fields of polymer chemistry, pharmacy and medicine and relates to a method by which for example medicaments as implant components are released in the environment of the implant. The aim of the invention is to provide a method which in a simple and easily reproducible manner produces a drug delivery system which releases medicaments in a locally targeted and controllably delayed manner. The aim is achieved by a method in which polyanions and polycations are mixed in a liquid in a non-stöchiometric ratio, based on the charged monomer units, wherein medicaments are added either before, during or after the mixing of the polyelectrolytes, or charge-carrying medicaments and an oppositely charged polyelectrolyte are mixed, and after mixing the resulting polyelectrolyte complex is applied to the surface of a medicinal agent or is positioned on the surface directly at the site where the medicament is to be released.